Hamilton EP, Kaklamani V, Falkson C, Vidal GA, et al. Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study. Clin Breast Cancer 2021 May 15. pii: S1526-8209(21)00089.
PMID: 34154926